Home › Funds › Krensavage Asset Management, LLC › BNTX

Krensavage Asset Management, LLC position in BNTX

BIONTECH SE · Health Care

Krensavage Asset Management, LLC reported holding 59,523 shares of BNTX (BIONTECH SE) in its Q2 2026 13F filing — a position valued at US$5.5M, representing 2.10% of its reported portfolio and ranking #11 among its reported holdings. Krensavage Asset Management, LLC has disclosed BNTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)59.52K sh
Reported value held$5.54M
Portfolio Weight2.10%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Krensavage Asset Management, LLC's BNTX position evolved

Krensavage Asset Management, LLC first disclosed a stake in BNTX in Q1 2024 at 120,000 shares (US$11.1M). The position peaked in Q3 2024 at 93,583 shares, worth US$11.1M. Across 10 filings, Krensavage Asset Management, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 59,523 shares valued at US$5.5M. Notable position changes include a 29% trim in Q3 2024 (shares fell 4% over the following quarter), a 25% increase in Q4 2025 (shares fell 7% over the following quarter), a 40% trim in Q1 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 120.00K $11.07M New
Q2 2024 132.29K $10.63M Add
Q3 2024 93.58K $11.12M Reduce
Q4 2024 88.66K $10.10M Reduce
Q1 2025 87.56K $7.97M Reduce
Q2 2025 73.38K $7.81M Reduce
Q3 2025 79.37K $7.83M Add
Q4 2025 99.52K $9.47M Add
Q1 2026 59.52K $5.29M Reduce
Q2 2026 59.52K $5.54M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTX and 13F data

BNTX (BIONTECH SE) is a Health Care company. 35 other funds we track also report a position in BNTX — the largest reported positions include FLOSSBACH VON STORCH SE (US$207.1M), Temasek Holdings (Private) Ltd (US$140.1M), Logos Global Management LP (US$94.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTX

All BNTX fund holders →

FAQ

How long has Krensavage Asset Management, LLC held BNTX?

Krensavage Asset Management, LLC has disclosed BNTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Krensavage Asset Management, LLC's current position in BNTX?

As of Q2 2026, Krensavage Asset Management, LLC holds 59.52K shares of BNTX (BIONTECH SE), valued at $5.54M, representing 2.10% of its reported portfolio and ranking #11.

Has Krensavage Asset Management, LLC been buying or selling BNTX?

In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in BNTX. The position peaked in Q3 2024 at 93.58K shares.

Which other funds hold BNTX?

Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Temasek Holdings (Private) Ltd, Logos Global Management LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.